🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT03299530
Recruiting Observational

Accuracy of Corneal Astigmatism in Different Region Modes

NCT03299530 · tracked via the Priya Life Science China tracker
Sponsor
Wenzhou Medical University
Phase
Observational
Started
2017-10-10
Last updated
2026-08-19

Condition(s) studied

AstigmatismCornea

Investigational drug(s) / intervention(s)

patients with corneal astigmatism

patients with corneal astigmatism: The total corneal astigmatism, anterior chamber depth, will be measured by a Scheimpflug tomographer. Pupil size will be measured by itrace device and MONCV3 device. Residual astigmatism will be tested by subjective refraction.

Study summary

To analyze the difference between measured total corneal astigmatism and actual corneal astigmatism under different region modes and optimize the region setting.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 18 years * Patients who had received phacoemulsification surgery with or without implantation of toric IOL are with a certain amount of corneal astigmatism. * Best corrected visual acuity ≥ 0.66 (20/30 Snellen) Exclusion Criteria: * Corneal diseases or severe irregular astigmatism (e.g., pterygium, keratoconus), existence of corneal opacification; * Ocular disease which may affect visual acuity (e.g., glaucoma, uveitis, retinal disease, pathologic myopia); * History of ocular surgery or ocular trauma before this cataract surgery; * Decentration of IOL \> 0.3mm or tilt \> 5° * Implantation of multifocal IOL * history of wearing of rigid contact lens within the past 4 weeks or soft contact lens within 1 week;

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Eye Hispital of Wenzhou Medical University Wenzhou Zhejiang Recruiting

More Wenzhou Medical University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03299530 on ClinicalTrials.gov ↗ ← All trials in China